UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 10-Q
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended: June 30, 2020
or
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from: to
Commission file number: 01-07698
ACME UNITED CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
Connecticut
06-0236700
State or Other Jurisdiction of
I.R.S. Employer Identification No.
Incorporation or Organization
55 Walls Drive, Fairfield, Connecticut
06824
Address of Principal Executive Offices
Zip Code
Registrant's telephone number, including area code: (203) 254-6060
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
$2.50 par value Common Stock
ACU
NYSE American
Indicate by check mark whether the registrant (l) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (sec. 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act (Check one).
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller Reporting Company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(s) of the Exchange Act ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Registrant had 3,336,413 shares of its $2.50 par value Common Stock outstanding as of August 3, 2020.
INDEX
Page
Number
Part I — FINANCIAL INFORMATION:
Item 1:
Financial Statements (Unaudited)
3
Condensed Consolidated Balance Sheets at June 30, 2020 and December 31, 2019
Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2020 and 2019
5
Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2020 and 2019
6
Condensed Consolidated Statement of Changes in Stockholders’ Equity for the three and six months ended June 30, 2020 and 2019
7
Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2020 and 2019
9
Notes to Condensed Consolidated Financial Statements
10
Item 2:
Management’s Discussion and Analysis of Financial Condition and Results of Operations
16
Item 3:
Quantitative and Qualitative Disclosures about Market Risk
20
Item 4:
Controls and Procedures
Part II — OTHER INFORMATION:
Legal Proceedings
21
Item 1A:
Risk Factors
Unregistered Sales of Equity Securities and Use of Proceeds
Defaults Upon Senior Securities
Mine Safety Disclosures
Item 5:
Other Information
Item 6:
Exhibits
Signatures
22
2
Part I - FINANCIAL INFORMATION
Item 1: Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
(all amounts in thousands)
June 30,
December 31,
2020
2019
(unaudited)
(Note 1)
ASSETS
Current assets:
Cash and cash equivalents
$
5,239
6,822
Accounts receivable, less allowance of $950 in 2020 and $523 in 2019
33,720
25,485
Inventories
44,311
39,261
Prepaid expenses and other current assets
2,438
1,578
Total current assets
85,708
73,146
Property, plant and equipment:
Land
1,421
1,420
Buildings
10,704
10,096
Machinery and equipment
19,833
19,112
31,958
30,628
Less: accumulated depreciation
17,681
16,592
14,277
14,036
Operating lease right-of-use asset, net
2,989
Goodwill
4,696
Intangible assets, less accumulated amortization
16,376
15,793
Other assets
41
89
Total assets
123,536
110,749
See Notes to Condensed Consolidated Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS (continued)
(all amounts in thousands, except share amounts)
LIABILITIES
Current liabilities:
Accounts payable
8,733
6,693
Operating lease liability - current portion
933
1,047
Current portion of mortgage payable
267
Other accrued liabilities
10,680
8,576
Total current liabilities
20,613
16,583
Non-current liabilities:
Long-term debt
35,742
33,240
Long-term debt - PPP Loan
3,508
-
Mortgage payable, net of current portion
3,044
3,178
Operating lease liability - non-current portion
1,573
1,961
Other non-current liabilities
49
83
Total liabilities
64,529
55,045
Commitments and Contingencies (see note 2)
STOCKHOLDERS' EQUITY
Common stock, par value $2.50:
authorized 8,000,000 shares;
issued - 4,838,071 shares in 2020 and 2019,
including treasury stock
12,094
Additional paid-in capital
8,304
8,262
Retained earnings
55,247
51,571
Treasury stock, at cost - 1,501,658 shares in 2020 and 1,487,238 in 2019
(14,522
)
(14,235
Accumulated other comprehensive loss:
Minimum pension liability
(522
Translation adjustment
(1,594
(1,466
(2,116
(1,988
Total stockholders’ equity
59,007
55,704
Total liabilities and stockholders’ equity
4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
(all amounts in thousands, except per share amounts)
Three Months Ended June 30,
Six Months Ended June 30,
Net sales
44,042
40,220
79,817
71,590
Cost of goods sold
27,989
25,449
50,234
45,016
Gross profit
16,053
14,771
29,583
26,574
Selling, general and administrative expenses
11,670
11,003
23,191
21,271
Operating income
4,383
3,768
6,392
5,303
Non-operating items:
Interest:
Interest expense
245
502
568
1,013
Interest income
(11
(14
(19
Interest expense, net
234
491
554
994
Other (income) expense, net
(1
14
37
12
Total other expense, net
233
505
591
1,006
Income before income tax expense
4,150
3,263
5,801
4,297
Income tax expense
951
592
1,325
819
Net income
3,199
2,671
4,476
3,478
Basic earnings per share
0.96
0.80
1.34
1.04
Diluted earnings per share
0.92
0.77
1.28
1.01
Weighted average number of common shares outstanding-denominator used for basic
per share computations
3,349
3,351
3,344
Weighted average number of dilutive stock options outstanding
132
134
155
78
Denominator used for diluted per share computations
3,482
3,485
3,499
3,429
Dividends declared per share
0.12
0.24
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Three Months Ended
Six Months Ended
Other comprehensive income (loss):
Foreign currency translation adjustment
201
80
(128
81
Comprehensive income
3,400
2,751
4,348
3,559
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
For the three months ended June 30, 2019
Outstanding Shares of Common Stock
Common Stock
Treasury
Stock
Additional Paid-In Capital
Accumulated
Other Comprehensive (Loss) Gain
Retained Earnings
Total
Balances, March 31, 2019
3,350,833
9,114
(2,179
48,074
52,868
Other comprehensive loss
Stock compensation expense
286
Distributions to shareholders
(404
Cash settlement of stock options
(699
Balances, June 30, 2019
8,701
(2,099
50,341
54,802
For the three months ended June 30, 2020
Balances, March 31, 2020
3,340,114
(14,449
8,048
(2,317
52,448
55,824
359
(400
(103
Purchase of treasury stock
(3,701
(73
Balances, June 30, 2020
3,336,413
For the six months ended June 30, 2019
Outstanding
Shares of
Common
Additional
Paid-In
Capital
Other
Comprehensive
(Loss) Gain
Retained
Earnings
Balances, December 31, 2018
8,982
(2,058
47,550
52,333
1
Adoption of ASU 2018-02
(42
122
498
(809
(779
For the six months ended June 30, 2020
Balances, December 31, 2019
602
(800
(560
(14,420
(287
See Notes to Condensed Consolidated Financial Statements.
8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Cash flows from operating activities:
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation
1,125
1,099
Amortization of intangible assets
659
623
Non-cash lease expense
47
11
Provision for bad debt
619
Changes in operating assets and liabilities:
Accounts receivable
(8,598
(10,258
(4,675
1,775
(414
161
1,633
1,845
1,864
Total adjustments
(6,829
(2,594
Net cash (used in) provided by operating activities
(2,353
884
Cash flows from investing activities:
Purchase of property, plant and equipment
(1,323
(759
Acquisition of First Aid Central
(2,074
Net cash used in investing activities
(3,397
Cash flows from financing activities:
Net borrowings (repayments) of long-term debt
2,502
(895
Proceeds from PPP Loan
Repayments on mortgage
(133
Purchase of treasury shares
Net cash provided by (used in) financing activities
4,230
(2,616
Effect of exchange rate changes on cash and cash equivalents
(63
Net change in cash and cash equivalents
(1,583
(2,485
Cash and cash equivalents at beginning of period
4,409
Cash and cash equivalents at end of period
1,924
Supplemental cash flow information:
Cash paid for income taxes
371
225
Cash paid for interest
548
997
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. Basis of Presentation
The accompanying condensed consolidated financial statements include all adjustments necessary to present fairly the financial position, results of operations and cash flows of Acme United Corporation (the “Company”). These adjustments are of a normal, recurring nature. However, the financial statements do not include all the disclosures normally required by accounting principles generally accepted in the United States of America or those normally made in the Company's Annual Report on Form 10-K. Please refer to the Company's Annual Report on Form 10-K for the year ended December 31, 2019 for such disclosures. The condensed consolidated balance sheet as of December 31, 2019 was derived from the audited consolidated balance sheet as of that date. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations and the financial statements and notes thereto included in the Company’s 2019 Annual Report on Form 10-K.
Certain reclassification of prior years’ amounts have been made to conform to the current years’ presentation.
The Company has evaluated events and transactions subsequent to June 30, 2020 and through the date these condensed consolidated financial statements were issued.
Recently Issued and Adopted Accounting Standards
In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20), Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans Income Statement - Reporting Comprehensive Income (Topic 220). This ASU removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. ASU 2018-14 is effective for fiscal years ending after December 15, 2020. The Company does not expect that the adoption of ASU 2018-14 will have a material impact on its consolidated financial statements.
In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The update eliminates, clarifies and modifies certain guidance related to the accounting for income taxes. ASU 2019-12 is effective for annual reporting periods beginning after December 15, 2020. The Company does not expect the adoption of ASU 2019-12 to have a material effect on its consolidated financial statements.
2. Commitment and Contingencies
There are no pending material legal proceedings to which the Company is a party, or, to the actual knowledge of the Company, contemplated by any governmental authority.
3. Revenue from Contracts with Customers
Nature of Goods and Services
The Company recognizes revenue from the sales of a broad line of products that are grouped into two main categories: (i) cutting, sharpening and measuring; and (ii) first aid and safety. The cutting, sharpening and measuring category includes scissors, knives, paper trimmers, pencil sharpeners and other sharpening tools. The first aid and safety category includes first aid kits and refills and a variety of safety products. Revenue recognition is evaluated through the following five steps: (i) identification of the contract or contracts with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price in the contract; and (v) recognition of revenue when or as a performance obligation is satisfied.
When Performance Obligations Are Satisfied
A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Revenue is generated by the sale of the Company’s products to its customers. Sales contracts (purchase orders) generally have a single performance obligation that is satisfied at a point in time, with shipment or delivery, depending on the terms of the underlying contract. Revenue is measured based on the consideration specified in the contract. The amount of consideration we receive and revenue we recognize is impacted by incentives ("customer rebates"), including sales rebates, which are generally tied to sales volume levels, in-store promotional allowances, shared media and customer catalogue allowances and other cooperative advertising arrangements; freight allowance programs offered to our customers; and allowance for returns and discounts. We generally recognize customer rebate costs as a deduction to gross sales at the time that the associated revenue is recognized.
Significant Payment Terms
Payment terms for each customer are dependent on the agreed upon contractual repayment terms. Payment terms typically are between 30 and 90 days and vary depending on the size of the customer and its risk profile to the Company. Some customers receive discounts for early payment.
Product Returns
The Company accepts product returns in the normal course of business. The Company estimates reserves for returns and the related refunds to customers based on historical experience. Reserves for returned merchandise are included as a component of “Accounts receivable” in the condensed consolidated balance sheets.
Practical Expedient Usage and Accounting Policy Elections
For the Company’s contracts that have an original duration of one year or less, the Company uses the practical expedient in ASC 606-10-32-18 applicable to such contracts and does not consider the time value of money in relation to significant financing components. The effect of applying this practical expedient election did not have an impact on the Company’s condensed consolidated financial statements.
Per ASC 606-10-25-18B, the Company has elected to account for shipping and handling activities that occur after the customer has obtained control as a fulfilment activity instead of a performance obligation. Furthermore, shipping and handling activities performed before transfer of control of the product also do not constitute a separate and distinct performance obligation. The effect of applying this practical expedient election did not have an impact on the Company’s condensed consolidated financial statements.
The Company has elected to exclude from the transaction price those amounts which relate to sales and other taxes that are assessed by governmental authorities and that are imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from a customer.
Applying the practical expedient in ASC 340-40-25-4, Other Assets and Deferred Costs, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred. These costs are included in “Selling, general and administrative expenses.” The effect of applying this practical expedient did not have an impact on the Company’s condensed consolidated financial statements.
Disaggregation of Revenues
The following table represents external net sales disaggregated by product category, by segment (amounts in thousands):
U.S.
Canada
Europe
Cutting, Sharpening and Measuring
19,699
1,247
2,891
23,837
First Aid and Safety
18,773
1,141
291
20,205
Total Net Sales
38,472
2,388
3,182
18,733
2,216
2,854
23,803
16,225
—
192
16,417
34,958
3,046
31,427
2,661
5,497
39,585
37,488
2,141
603
40,232
68,915
4,802
6,100
31,931
3,628
5,045
40,604
30,492
494
30,986
62,423
5,539
4. Debt and Shareholders’ Equity
Long-term debt consists of borrowings under the Company’s revolving loan agreement with HSBC Bank, N.A. The agreement provides for borrowings of up to $50 million at Prime Rate less 1.25%. The credit facility has an expiration date of May 24, 2023. The Company must pay a facility fee, payable quarterly, in an amount equal to two tenths of one percent (.20%) per annum of the average daily unused portion of the revolving credit line. The facility is intended to provide liquidity for working capital, growth, dividends, acquisitions, share repurchases and other business activities. Under the revolving loan agreement, the Company is required to maintain specific amounts of tangible net worth, a specified debt to net worth ratio and a fixed charge coverage ratio and must have annual net income greater than zero, measured as of the end of each fiscal year. At June 30, 2020, the Company was in compliance with the covenants then in effect under the loan agreement.
As of June 30, 2020, and December 31, 2019, the Company had outstanding borrowings of $35,742,167 and $33,240,407, respectively, under the Company’s revolving loan agreement with HSBC.
On October 26, 2017, the Company exercised its option to purchase its First Aid Only manufacturing and distribution center in Vancouver, WA for $4.0 million. The property consists of 53,000 square feet of office, manufacturing, and warehouse space on 2.86 acres. The purchase was financed by a variable rate mortgage with HSBC Bank, N.A. at an interest rate of LIBOR plus 2.5%. Commencing on December 1, 2017, principal payments of $22,222 are due monthly, with all amounts outstanding due on maturity on October 31, 2024.
During the three and six months ended June 30, 2020 the Company paid approximately $103,000 and $560,000, respectively, to optionees who had elected a net cash settlement of their respective employee stock options.
During the three and six months ended June 30, 2020, the Company paid approximately $73,000 and $287,000, respectively, to repurchase a total of 3,701 and 14,420 shares of its Common Stock under its 2010 stock repurchase program. As of June 30, 2020, a total of 203,579 additional shares may be purchased in the future under the repurchase programs announced in 2010 and 2019.
5. Segment Information
The Company reports financial information based on the organizational structure used by the Company’s chief operating decision makers for making operating and investment decisions and for assessing performance. The Company’s reportable business segments consist of: (1) United States; (2) Canada; and (3) Europe. As described below, the activities of the Company’s Asian operations are closely linked to those of the U.S. operations; accordingly, the Company’s chief operating decision makers review the financial results of both on a consolidated basis, and the results of the Asian operations have been aggregated with the results of the United States operations to form one reportable segment called the “United States segment” or “U.S. segment”. Each reportable segment derives its revenue from the sales of cutting and sharpening devices, measuring instruments and first aid and safety products for school, office, home, hardware, sporting and industrial use.
Domestic sales orders are filled primarily from the Company’s distribution centers in North Carolina, Washington, Massachusetts, Tennessee and California. The Company is responsible for the costs of shipping, insurance, customs clearance, duties, storage and distribution related to such products. Orders filled from the Company’s inventory are generally for less than container-sized lots.
Direct import sales are products sold by the Company’s Asian subsidiary, directly to major U.S. retailers, who take ownership of the products in Asia. These sales are completed by delivering product to the customers’ common carriers at the shipping points in Asia. Individual direct import sales are made in larger quantities than domestic sales, typically full containers. Direct import sales represented approximately 14% and 11% of the Company’s total net sales for the three and six months ended June 30, 2020, respectively, compared to 19% and 14% for the comparable periods in 2019.
The Chief Operating Decision Maker evaluates the performance of each operating segment based on segment revenues and operating income. Segment revenues are defined as total revenues, including both external customer revenue and inter-segment revenue. Segment operating earnings are defined as segment revenues, less cost of goods sold and operating expenses. Identifiable assets by segment are those assets used in the respective reportable segment’s operations. Inter-segment amounts are eliminated to arrive at consolidated financial results.
The following table sets forth certain financial data by segment for the three and six months ended June 30, 2020 and 2019:
Financial data by segment:
(in thousands)
Three months ended June 30,
Six months ended
Sales to external customers:
United States
38,476
68,922
2,381
4,800
3,185
6,095
Consolidated
Operating income:
3,685
3,271
5,253
4,529
366
360
573
495
332
137
566
279
Consolidated income before income taxes
Assets by segment:
109,807
98,578
6,538
6,168
7,191
6,003
6. Stock Based Compensation
The Company recognizes share-based compensation at the fair value of the equity instrument on the grant date. Compensation expense is recognized over the required service period, which is generally the vesting period of the equity instrument. Share-based compensation expenses were $359,000 and $602,181, respectively, for the three and six months ended June 30, 2020, respectively, compared to $286,000 and $498,000 for the three and six months ended June 30, 2019, respectively.
As of June 30, 2020, there was a total of $1,239,929 of unrecognized compensation cost, adjusted for estimated forfeitures, related to non-vested share-based payments granted to the Company’s employees. As of that date, the remaining unamortized expense is expected to be recognized over a weighted average period of approximately three years.
7. Fair Value Measurements
The carrying value of the Company’s bank debt is a reasonable estimate of fair value because of the nature of its payment terms and maturity.
8. Leases
The Company has operating leases for office and warehouse space and equipment under various arrangements which provide the right to use the underlying asset and require lease payments for the lease term. The Company’s lease portfolio consists of operating leases which expire at various dates through 2026.
Certain of the Company’s lease arrangements contain renewal provisions, exercisable at the Company's option. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.
The Company determines if an arrangement is an operating lease at inception. Leases with an initial term of 12 months or less are not recorded on the balance sheet. All other leases are recorded on the balance sheet with right-of-use (“ROU”) assets representing the right to use the underlying asset for the lease term and lease liabilities representing the obligation to make lease payments arising from the lease.
13
ROU assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term and include options to extend or terminate the lease when they are reasonably certain to be exercised. As most of our leases do not provide an implicit rate, the present value of lease payments is determined primarily using our incremental borrowing rate based on the information available at the lease commencement date. The incremental borrowing rate is the rate of interest that we would have to pay to borrow on a collateralized basis over a similar term on an amount equal to the lease payments in a similar economic environment. Lease agreements with lease and non-lease components are generally accounted for as a single lease component. The Company’s operating lease expense is recognized on a straight-line basis over the lease term. For the three months ended June 30, 2020, lease expense in the amount of $0.1 million was included in cost of goods sold and $0.2 million was included in selling, general and administrative expenses in the accompanying condensed consolidated statement of operations. For the six months ended June 30, 2020, lease expense in the amount of $0.2 million was included in cost of goods sold and $0.4 million was included in selling, general and administrative expenses in the accompanying condensed consolidated statement of operations.
Information related to leases (in 000’s):
Three months ended
June 30, 2020
June 30, 2019
Operating lease cost
308
Operating lease - cash flow
296
615
581
567
570
Weighted-average remaining lease term
4.0 years
3.2 years
Weighted-average discount rate
%
Future minimum lease payments under non-cancellable leases as of June 30, 2020:
2020 (remaining)
541
2021
735
2022
467
2023
462
2024
278
Thereafter
294
Total future minimum lease payments
2,777
Less: imputed interest
(271
Present value of lease liabilities - current
Present value of lease liabilities - non-current
9. Business Combinations
On January 7, 2020, the Company purchased the assets of First Aid Central, a Canadian first aid and safety supplier, based in Laval, Canada for approximately $2.1 million in cash. First Aid Central products consist of a broad line of first aid kits, refills, and safety products that are sold to a wide range of industries and end users. The products meet federal Health Canada and provincial regulatory requirements.
The purchase price was allocated to assets acquired as follows (in thousands):
Assets:
232
Inventory
440
Prepaid Expense
Equipment
45
Intangible assets
1,310
2,074
The acquisition was accounted for as a business combination, pursuant to ASC 805 – Business Combinations. All assets acquired in the acquisition are included in the Company’s Canada segment. Management’s assessment of the valuation of intangible assets is preliminary and finalization of the Company’s purchase price accounting assessment may result in changes to the valuation of the identified intangible assets.
Net sales for the three and six months ended June 30, 2020 attributable to the sales of First Aid Central products were approximately $1.1 million and $2.1 million, respectively. Net income for the three and six months ended June 30, 2020 attributable to First Aid Central products was approximately $0.1 million and $0.2, respectively.
Assuming First Aid Central assets were acquired on January 1, 2019, unaudited proforma combined net sales for the three months ended June 30, 2019, for the Company would have been approximately $41.2 million. Unaudited proforma combined net income for the three months ended June 30, 2019 for the Company would have been approximately $2.8 million. Unaudited proforma combined net sales for the six months ended June 30, 2019 for the Company would have been approximately $73.3. Unaudited proforma combined net income for the six months ended June 30, 2019 for the Company would have been approximately $3.7 million
10. Paycheck Protection Program Loan
On May 7, 2020, the Company received a loan (the “PPP Loan”) from HSBC Bank, N.A. in the amount of $3,508,047 under the Paycheck Protection Program established by the Coronavirus Aid, Relief and Economic Security Act. Subject to potential forgiveness, as described below, the PPP Loan matures in two years on May 8, 2022, bears interest at a rate of 1.00% per year and is evidenced by a promissory note dated May 7, 2020 (the “Note”). Monthly payments of principal and interest are deferred until after any application for forgiveness submitted by the Company has been acted upon, as described below. The PPP Loan is unsecured and federally guaranteed. The Note contains customary events of default relating to, among other things, failure to make payments of principal and interest and breaches of representations and warranties. The Company may prepay the PPP Loan at any time prior to maturity with no penalty.
All or a portion of the PPP Loan may be eligible to be forgiven by the U.S. Small Business Administration (“SBA”) and the lender upon application by the Company, provided that the Company shall have used the loan proceeds for eligible purposes, including the payment of payroll, benefits, rent, mortgage interest and utilities, during the [24] week period beginning on the date of funding of the loan (the “covered period”). Not more than 40% of the amount forgiven may be for non-payroll costs. The Company will be eligible to submit an application for forgiveness of the PPP Loan for a period of up to ten months after the end of the covered period.
Consistent with the requirements of the PPP for loan forgiveness, the Company has been using the loan proceeds solely for payment of payroll and otherwise in a manner which it believes satisfy the requirements for loan forgiveness. However, no assurance can be given that any application for loan forgiveness that the Company may submit will be approved, in whole or in part.
15
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Information
The Company may from time to time makes written or oral “forward-looking statements” including statements contained in this report and in other communications by the Company, which are made in good faith pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on our beliefs as well as assumptions made by and information currently available to us. When used in this document, words like “may,” “might,” “will,” “except,” “anticipate,” “believe,” “potential,” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from our current expectations.
Forward-looking statements in this report, including without limitation, statements related to the Company’s plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties including the impact that the global COVID-19 pandemic has had and will continue to have on the Company’s business, operations and financial results. These include the severity and duration of the pandemic, whether there is a “second wave,” the effect of measures taken by the Company to limit the spread of the disease at our offices and distribution centers, further actions that may be taken by governmental authorities or by businesses or individuals on their own initiative in response to the pandemic, the pace of recovery when an effective vaccine is widely available or when the pandemic otherwise subsides and the heightened impact the pandemic has on many of the risks described herein, including without limitation risks relating to the on-going world-wide economic downturn and disruptions in our supply chain,, any of which could adversely impact the Company’s ability to manufacture, source or distribute its products, both domestically and internationally.
These risks and uncertainties further include, without limitation, the following: (i) changes in the Company’s plans, strategies, objectives, expectations and intentions, which may be made at any time at the discretion of the Company; (ii) the impact of uncertainties in global economic conditions, including the impact on the Company’s suppliers and customers; (iii) changes in client needs and consumer spending habits; (iv) the impact of competition, (v) the impact of technological changes including specifically the growth of online marketing and sales activity; (vi) the Company’s ability to manage its growth effectively, including its ability to successfully integrate any business it might acquire; (vii) the Company’s ability to effectively manage its inventory in a rapidly changing business environment; (viii) currency fluctuations; (ix) international trade policies and their impact on demand for our products and our competitive position, including the imposition of new tariffs or changes in existing tariff rates; and (x) other risks and uncertainties indicated from time to time in the Company’s filings with the Securities and Exchange Commission.
For a more detailed discussion of these and other factors affecting the Company, see the Risk Factors described in Item 1A included in the Company’s Annual Report on Form 10-K for the fiscal year December 31, 2019 and below under “Financial Condition”. All forward-looking statements in this report are based upon information available to the Company on the date of this report. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.
Critical Accounting Policies
We discuss our critical accounting policies and estimates in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019.
COVID-19 Pandemic Related Considerations
As noted above in the “Forward-Looking Statements”, the spread of the coronavirus (COVID-19) through China, the United States, and other countries globally and the related ongoing economic downturn present certain significant risks and uncertainties to the Company and its operations. Commencing late in the first quarter of the current fiscal year and continuing through the filing of this report, the COVID-19 pandemic has affected the Company’s financial results and business operations. During this period, we experienced, and continue to experience, a significant increase in demand for many of the Company’s first aid and safety products, as consumers and commercial enterprises stocked up on these products. On the other hand, the Company experienced weakness in the sales of its office and school supplies due, in part, to pandemic-related closures of retail stores, schools and offices and other COVID-19 related restrictions imposed in our domestic and international markets. The Company has also experienced delays and cancellation of orders and scheduled promotions for the second and third quarters, which are traditionally the strongest quarters for the sales of our school and office products. The ultimate impact of these effects on the Company will depend on the duration and severity of the COVID-19 pandemic, the length of time it takes for normal economic and operating conditions to resume, whether store, office, and school closures and other restrictions that have been imposed to date are extended, and additional actions that may be taken by governmental authorities or by businesses or individuals of their own initiative in response to the pandemic.
Substantially all of our manufacturing facilities and distribution centers and those of our key suppliers currently remain open and continue to operate despite temporary closures. We monitor information on COVID-19 from the Centers for Disease Control and Prevention (“CDC”) and believe we are adhering to their recommendations regarding the health and safety of our personnel. To address the potential human impact of the virus, most of our administrative staff are telecommuting. For those administrative staff not telecommuting and our warehouse and domestic manufacturing employees, we have implemented social distancing and mask policies, instituted daily temperature checks and have increased facility cleaning at each location. Non-essential domestic and international travel for our employees has ceased.
As a result of the COVID-19 pandemic, commencing later in the first quarter and continuing into our second quarter the Company (i) has had to acquire certain of its products at increased costs on the spot market due to dramatic increases in demand for such products (while, to date, the Company has been successful in passing along such increased costs to its customers, there is no assurance that the Company will be able to continue to do so in the future); (ii) has incurred increased labor costs as a result of the payment of additional compensation to employees at its warehouse and distribution centers; and (iii) has incurred costs associated with the additional cleaning and maintenance of its facilities including the temporary closures of facilities for those purposes. The Company has continued to incur such costs as a result of these conditions in the third quarter. In addition, the Company has increased reserves relating to outstanding receivables (The Company continuously evaluates credit risks relating to its customers and may need to increase its reserves relating to its receivables further or even, in the event that one or more significant customers should cease operations or declares bankruptcy, write off a substantial amount of receivables.) The Company has also experienced obstacles resulting from a number of pandemic-related factors such as travel restrictions imposed by governmental authorities which, e.g., inhibit sales and marketing activities, and inefficiencies resulting from many of the Company’s personnel working remotely.
The increases and decreases in the demand for the Company’s products described above have continued to affect the Company’s operations in the second quarter and through the date of this report and are likely to continue to do so in the immediate future. For example, a decrease could occur in the demand for its first aid and safety products as a result of market saturation potentially resulting from customers having stockpiled those products. While there is no certainty that the current high levels of demand for our first aid and safety products will continue, we have increased our short-term manufacturing and sourcing capacity for these products. We are also planning to increase manufacturing and sourcing of other key components and finished goods to minimize the impact of any disruption to our supply chain in the event of a resurgence of an outbreak of the coronavirus in any of our key manufacturing or distribution facilities. The Company anticipates that it has sufficient inventory of its products to meet anticipated demand. However, any prolonged increase in the duration or severity of the COVID-19 pandemic or a resurgence of the pandemic in the future, might adversely affect the Company’s ability to manufacture, source or distribute its products both domestically and internationally. The occurrence of any of these factors could have a material adverse effect on the Company’s business, operations and financial condition.
Results of Operations
Traditionally, the Company’s sales are stronger in the second and third quarters and weaker in the first and fourth quarters of the fiscal year, due to the seasonal nature of the back-to-school market.
Consolidated net sales for the three months ended June 30, 2020 were $44,042,000 compared with $40,220,000 in the same period in 2019, a 10% increase. Consolidated net sales for the six months ended June 30, 2020 were $79,817,000 compared with $71,590,000 in the same period in 2019, an 11% increase. Net sales for the three and six months ended June 30, 2020 in the U.S. segment increased 10%, compared with the same period in 2019. Sales in the U.S. for the three and six month periods increased compared to the same period last year, primarily due to strong sales of first aid and safety products, primarily due to continued market share gains in the industrial and safety channels, as well as the home improvement, mass market and ecommerce channels. Also contributing to the growth in first aid products was the continuation of a surge demand related to the COVID-19 pandemic which had commenced late in the first quarter.
Net sales in Canada for the three and six months ended June 30, 2020, increased 7% and 32% (11% and 35% in local currency), respectively, compared to the same periods last year. Excluding First Aid Central products, sales for the three and six months ended June 30, 2020 decreased 44% and 27%, respectively, in U.S. dollars (42% and 25% local currency), compared with the same periods in 2019. Sales of First Aid Central products were approximately $1.0 million and $2.1 million in the three and six months ended June 30, 2020.
European net sales for the three and six months ended June 30, 2020 increased 5% and 10%, respectively, in U.S. dollars (6% and 12% in local currency), compared with the same periods in 2019. The increase in net sales for the three and six months was primarily due to increased sales of Westcott and Camillus products in the e-commerce channel as well as continued growth of DMT sharpening products.
17
Gross profit for the three months ended June 30, 2020 was $16,053,000 (36.4% of net sales) compared to $14,771,000 (36.7% of net sales) in the same period in 2019. Gross profit for the six months ended June 30, 2020 was $29,583,000 (37.1% of net sales) compared to $26,574,000 (37.1% of net sales) for the same period in 2019.
Selling, general and administrative ("SG&A") expenses for three months ended June 30, 2020 were $11,670,000 (26.5% of net sales) compared with $11,003,000 (27.4% of net sales) in the same period in 2019, an increase of $667,000. SG&A expenses for the six months ended June 30, 2020 were $23,191,000 (29.1% of net sales) compared with $21,271,000 (29.7% of net sales) for the same periods of 2019, an increase of $1,920,000. The increases in SG&A expenses for three and six months ended June 30, 2020, compared to the same periods in 2019 were primarily due to higher commissions and shipping costs related to higher sales, provision for bad debt primarily related to the impact of COVID-19 on our customers, as well as added expenses related to the acquisition of First Aid Central partially offset by lower travel and marketing expenses.
Operating income for the three months ended June 30, 2020 was $4,383,000 compared with $3,768,000 in the same period of 2019. Operating income for the six months ended June 30, 2020 was $6,392,000 compared with $5,303,000 in the same period of 2019. Operating income in the U.S. segment increased by $414,000 and $724,000 for the, three and six months ended June 30, 2020, respectively, compared to the same periods in 2019.
Operating income in the Canadian segment increased by $6,000 and $78,000 for the three and six months ended June 30, 2020 compared to the same periods in 2019.
Operating income in the European segment increased by $195,000 and $287,000 for the three and six months ended June 30, 2020 compared to the same periods in 2019.
Interest expense, net for the three months ended June 30, 2020 was $234,000 compared with $491,000 in the same period of 2019, a $257,000 decrease. Interest expense, net for the six months ended June 30, 2020 was $554,000 compared with $994,000 for the same period of 2019, a $440,000 decrease. The decrease in interest expense resulted from a lower average interest rate as well as lower average debt outstanding, under the Company’s revolving credit facility.
Other income, net was $1,000 in the three months ended June 30, 2020 compared to other expense, net of $14,000 in the same period of 2019. The increase in other income, net for the three months ended June 30, 2020 was primarily due to gains from foreign currency transactions. Other expense, net was $37,000 compared to $12,000 in the same period of 2019.
Income taxes
The Company’s effective tax rates for the three and six months ended June 30, 2020 were 23% and 21%, compared to 18% and 19% in the same periods in 2019.
Financial Condition
Liquidity and Capital Resources
During the first six months of 2020, working capital increased approximately $8.6 million compared to December 31, 2019. Inventory increased approximately $5.1 million at June 30, 2020 compared to December 31, 2019. The increase primarily reflected an increase in volume of sales and greater than usual costs of first aid and safety products on the “spot” market. Inventory turnover, calculated using a twelve-month average inventory balance, was 2.4 at June 30, 2020 compared to 2.1 at December 31, 2019. Receivables increased by approximately $8.2 million at June 30, 2020 compared to December 31, 2019. The average number of days sales outstanding in accounts receivable was 60 days at June 30, 2020 compared to 66 days at December 31, 2019. Accounts payable and other current liabilities increased by approximately $4.1 million at June 30, 2020 compared to December 31, 2019.
18
The Company's working capital, current ratio and long-term debt to equity ratio are as follows:
Working capital
65,095
56,563
Current ratio
4.16
4.41
Long term debt to equity ratio
71.7
65.4
During the first six months of 2020, total debt outstanding under the Company’s revolving credit facility increased by approximately $6.0 million, compared to total debt thereunder at December 31, 2019. As of June 30, 2020, $35,742,000 was outstanding and $14,258,000 was available for borrowing under the Company’s credit facility.
Long-term debt consists of borrowings under the Company’s revolving loan agreement with HSBC Bank, N.A. as well as amounts outstanding under the variable rate mortgage related on the Company’s manufacturing and distribution facility in Vancouver, WA. At June 30, 2020, there was approximately $3.3 million outstanding on the mortgage. The revolving loan agreement provides for borrowings of up to $50 million at Prime Rate less 1.25%. The credit facility has an expiration date of May 24, 2023. The Company must pay a facility fee, payable quarterly, in an amount equal to two tenths of one percent (.20%) per annum of the average daily unused portion of the revolving credit line. The facility is intended to provide liquidity for working capital, growth, dividends, acquisitions, share repurchases and other business activities. Under the revolving loan agreement, the Company is required to maintain specific amounts of tangible net worth, a specified debt to net worth ratio and a fixed charge coverage ratio and must have annual net income greater than zero, measured as of the end of each fiscal year. At June 30, 2020, the Company was in compliance with the covenants then in effect under the loan agreement.
As described above, commencing late in the first quarter, the Company has encountered challenges as a result of the COVID-19 pandemic and related economic downturn that could have adverse consequences for our liquidity as a result of a number of factors. Commencing late in the first quarter, the Company experienced a surge in the ordering of its first aid and safety products. It is uncertain whether such increases will continue and, in fact, decreases could occur if the market becomes saturated with unused first aid and safety products. Further, as stated above, the Company continues to experience weakened sales of school and office products. Additionally, as noted above, the Company has incurred and continues to incur increased operational and other expenses as a result of the COVID-19 pandemic. As discussed above, it is possible that the Company’s sourcing of products may be disrupted if the operations of the Company’s suppliers particularly those located in China, are interrupted by the effects of COVID-19. In order to address problems that may arise as a result of any such potential disruption, the Company is planning to increase its inventory of Westcott cutting and other products above customary levels.
On April 28, 2020, the U.S. Department of the Treasury stated that the SBA will review each PPP loan over $2.0 million. In order to apply for the PPP Loan, we were required to certify, among other things, that the then current uncertainty made the PPP Loan request necessary to support our ongoing operations. We made this certification in good faith after analyzing, among other things, our financial situation and access to alternative sources of capital. Following this analysis, we believe that we satisfied all eligibility criteria for the PPP Loan, and that our receipt of the PPP Loan is consistent with the objectives of the PPP of the CARES Act. If it is later determined that we were ineligible to receive the PPP Loan, we may be required to repay the PPP Loan in its entirety and/or be subject to additional penalties, which could have a material adverse effect on our business, results of operations and financial condition.
The Company believes that cash generated from operating activities, together with proceeds of the PPP Loan and funds available under its revolving credit facility, will, under current conditions, be sufficient to finance the Company’s operations over the next twelve months from the filing of this report.
19
Item 3: Quantitative and Qualitative Disclosure about Market Risk
Not applicable.
Item 4: Controls and Procedures
(a)
Evaluation of Internal Controls and Procedures
Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of June 30, 2020. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures are effective.
(b)
Changes in Internal Control over Financial Reporting
During the quarter ended June 30, 2020, there were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1 — Legal Proceedings
There are no pending material legal proceedings to which the registrant is a party, or, to the actual knowledge of the Company, contemplated by any governmental authority.
Item 1A — Risk Factors
See Risk Factors set forth in Part I, Item 1A of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2019.
Item 2 — Unregistered Sales of Equity Securities and Use of Proceeds
The table below lists shares repurchased by the Company during the three months ended June 30, 2020. All shares were repurchased in open market transactions under the repurchase program announced by the Company in 2010(1).
Period
Total Number of Shares Purchased
Average Price Paid per Share
Total Number of shares Purchased as Part of Publicly Announced Programs
Maximum Number of Shares that may yet be Purchased Under the Programs (2)
April
3,701
19.85
203,579
May
June
1) A total of 3,579 shares remain available for repurchase under the plan announced in 2010.
2) In addition to the repurchase plan announced in 2010, the Company announced a repurchase plan in 2019. The Plan
allows for the repurchase of up to a total of 200,000 shares.
Item 3 — Defaults upon Senior Securities
None.
Item 4 — Mine Safety Disclosures
Item 5 — Other Information
Item 6 — Exhibits
Documents filed as part of this report:
Exhibit 31.1
Certification of Walter C. Johnsen pursuant to 18 U.S.C. Section 1350, as adopted pursuant Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 31.2
Certification of Paul G. Driscoll pursuant to 18 U.S.C. Section 1350, as adopted pursuant Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 32.1
Certification of Walter C. Johnsen pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Exhibit 32.2
Certification of Paul G. Driscoll pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS
Inline XBRL Instance Document.
101.SCH
Inline XBRL Taxonomy Extension Schema Document.
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document.
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document.
104
The cover page for the Company’s Quarterly Report on Form 10-Q has been formatted in Inline XBRL and contained in Exhibit 101
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
By
/s/ Walter C. Johnsen
Walter C. Johnsen
Chairman of the Board and
Chief Executive Officer
Dated: August 7, 2020
/s/ Paul G. Driscoll
Paul G. Driscoll
Vice President and
Chief Financial Officer